share_log

Iovance Biotherapeutics | 8-K: Iovance Biotherapeutics Reports Second Quarter and First Half 2023 Financial Results and Corporate Updates

SEC announcement ·  Aug 8, 2023 16:05
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more